Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: Role for CAPON and Ang II

Cardiovascular Research

Volumn 92, Issue 2, 2011, Pages 348-357

  Sharma, Neeru M ^a   Zheng, Hong ^a   Mehta, Parmender P ^b   Li, Yi Fan ^c   Patel, Kaushik P ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

CAPON; Chronic heart failure; nNOS; Paraventricular nucleus; Sympathetic nerve activity

Indexed keywords

ANGIOTENSIN II; CARBOXY TERMINAL PDZ LIGAND OF NEURONAL NITRIC OXIDE SYNTHASE; LOSARTAN; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC DIAMETER; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC DIAMETER; HEART VENTRICLE SIZE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SYMPATHOEXCITATION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELL LINE, TUMOR; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INHIBITORS; HEART FAILURE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KIDNEY; LOSARTAN; MALE; MICROINJECTIONS; NITRIC OXIDE SYNTHASE TYPE I; OMEGA-N-METHYLARGININE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, N-METHYL-D-ASPARTATE; RNA INTERFERENCE; RNA, MESSENGER; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 80054091696     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr217     Document Type: Article

References (43)

1. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988;77:721-730. (Pubitemid 18093492)
2. Li YF, Cornish KG, Patel KP. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res 2003;93:990-997. (Pubitemid 37433237)
3. Zheng H, Li Y-F, Wang W, Patel KP. Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am J Physiol Regul Integr Comp Physiol 2009;297:R1364-R1374.
4. Hasking GJ, Esler MD, Jennings GL, Burton D, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardio-renal sympathetic nervous activity. Circulation 1986;73:615-621. (Pubitemid 16081418)
5. Liu JL, Irvine S, Reid IA, Patel KP, Zucker IH. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure-a role for angiotensin II. Circulation 2000;102:1854-1862.
6. Patel KP, Zhang PL, Krukoff TL. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol Regul Integr Comp Physiol 1993;265:R923-R928.
7. Kannan H, Niijima A, Yamashita H. Effects of stimulation of the hypothalamic paraventricular nucleus on blood pressure and renal sympathetic nerve activity. Brain Res Bull 1988;20:779-783. (Pubitemid 19266465)
8. Swanson LW, Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 1980;31:410-417. (Pubitemid 11250989)
9. Commons KG, Pfaff DW. Ultrastructural evidence for enkephalin mediated disinhibition in the ventromedial nucleus of the hypothalamus. J Chem Neuroanat 2001;21: 53-62. (Pubitemid 32155391)
10. Zhang K, Mayhan WG, Patel KP. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol 1997;273:R864-R872. (Pubitemid 27425632)
11. Li Y-F, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: altered inhibitory mechanisms. Acta Physiol Scand 2003; 177:17-26. (Pubitemid 36062551)
12. Schuman EM, Madison DV. Nitric oxide and synaptic function. Ann Rev Neurosci 1994; 17:153-183. (Pubitemid 24117028)
13. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH. CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 1998;20:115-124. (Pubitemid 28078354)
14. Bredt DS, Synder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-9033. (Pubitemid 20010361)
15. Garthwaite J, Garthwaite G, Palmer RMJ, Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989; 172:413-416. (Pubitemid 19258411)
16. Jaffrey SR, Benfenati F, Snowman AM, Czernik AJ, Snyder SH. Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proc Natl Acad Sci USA 2002;99:3199-3204. (Pubitemid 34240609)
17. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol 2008;294:R1863-R1872.
18. Li YF, Wang W, Mayhan WG, Patel KP. Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Integr Comp Physiol 2006;290:R1035-R1043.
19. Kinugawa T, Ogino K, kitamura H, Saitoh M, Omodani H, Osaki S et al. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am J Med Sci 1996;312:110-117. (Pubitemid 26308110)
20. Sumners C, Fleegal MA, Zhu M. Angiotensin AT1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 2002;29:483-490. (Pubitemid 34535373)
21. Kleiber AC, Zheng H, Sharma NM, Patel KP. Chronic AT1 receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure. Am J Physiol Heart Circ Physiol 2010;1152:1546-1555.
22. Zhang K, Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am J Physiol 1998;275:R728-R734.
23. Goncalves ARR, Fujihara CK, Matter AL, Malheiros DMAC, Noronha IL, De Nucci G et al. Renal expression of COX-2, Ang II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. Am J Physiol 2004;F945-F954. (Pubitemid 38508995)
24. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. Orlando: Academic Press, 1986.
25. Palkovits M, Brownstein M. Brain microdissection techniques. In: Cuello AE, ed. Brain Microdissection Techniques. Chichester: John Wiley & Sons, 1983.
26. Zheng H, Li YF, Cornish KG, Zucker IH, Patel KP. Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure. Am J Physiol Heart Circ Physiol 2005;288:H2332- H2341. (Pubitemid 40604122)
27. Patel KP, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Proc Soc Exp Biol Med 2001;226:814-824. (Pubitemid 34053230)
28. Li YF, Roy SK, Channon KM, Zucker IH, Patel KP. Effect of in vivo gene transfer of nNOS in the PVN on renal nerve discharge in rats. Am J Physiol Heart Circ Physiol 2002;282:H594-H601. (Pubitemid 34654983)
29. Bredt DS. Targeting nitric oxide to its targets. Proc Soc Exp Biol Med 1996;211:41-48.
30. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha-1 syntrophin mediated by PDZ domains. Cell 1996;84:757-767. (Pubitemid 26094205)
31. Fang MJS, Sawa A, Ye K, Luo X, Snyder SH. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 2000;28:183-193.
32. Che YH, Tamatani M, Tohyama M. Changes in mRNA for post-synaptic density-95 (PSD-95) and carboxy-terminal PDZ ligand of neuronal nitric oxide synthase following facial nerve transection. Mol Brain Res 2000;76:325-335. (Pubitemid 30179769)
33. Herman JP, Eyigor O, Ziegler DR, Jennes L. Expression of ionotropic glutamate receptor subunit mRNAs in the hypothalamic paraventricular nucleus of the rat. J Comp Neurol 2000;422:352-362. (Pubitemid 30387667)
34. Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 2003;1003:318-327. (Pubitemid 38083065)
35. Chang KC, Barth AS, Sasano T, Kizana E, Kashiwakura Y, Zhang Y et al. CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart. Proc Natl Acad Sci USA 2008;105:4477-4482. (Pubitemid 351754405)
36. Carrel D, Du Y, Komlos D, Hadzimichalis NM, Kwon M,Wang B et al. NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J Neurosci 2009;29:8248-8258.
37. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998;83:867-875. (Pubitemid 28068907)
38. Karson CN, Griffin WS, Mrak RE, Husain M, Dawson TM, Snyder SH et al. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol Chem Neuropathol 1996;27:275-284. (Pubitemid 26142651)
39. Johnson AK, Grippo AJ. Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006;57:5-29. (Pubitemid 46569831)
40. Depression Can Break Your Heart. NIH Publication No. 01-4592. Bethesda: National Institute of Mental Health.
41. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002;91:1038-1045. (Pubitemid 35416641)
42. Guggilam A, haque M, Kerut EK, McIlwain E, Lucchesi P, Seghal I et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am J Physiol Heart Circ Physiol 2007;293: H599-H609. (Pubitemid 47105121)
43. Omura T, Yoshiyama M, Matsumoto R, Kusuyama T, Enomoto S, Nishiya D et al. Role of c-Jun NH2-terminal kinase in G-protein-coupled receptor agonist-induced cardiac plasminogen activator inhibitor-1 expression. J Mol Cell Cardiol 2005;38: 583-592. (Pubitemid 40461822)